Caribou Biosciences's total assets for Q4 2025 were $179.63M, a decrease of -7.87% from the previous quarter. CRBU total liabilities were $57.46M for the fiscal quarter, a 8.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.